Skip to content

Author

A. Kapoor

We have 2 of 49 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Histological Spectrum and Determinants of Survival in Malignant Mesothelioma: Multivariate Analysis from a Five-Year North Indian Tertiary Cancer Center Cohort

Findings underscore the importance of tumor biology over environmental factors in survival and highlight the need for early detection and novel therapeutic strategies in MM.

P. Majumdar, Sonal Tripathi, Paramita Paul et al. · 0 citations
Review Aug 2026

KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms

KRAS-mutant NSCLC is transitioning from historically untargetable disease to a therapeutically actionable subset, and future progress hinges on resistance-directed combinations, biomarker-guided personalization, expansion to non-G12C mutants, and evaluation in earlier disease settings.

A. Kapoor, Bipinesh Sansar, Anuj Gupta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.